The Mini-Gastric Bypass

       

Studies show the MGB is More Effective than the LAP-BAND®* / Safer than the RNY Gastric Bypass**

 

Exit Strategy

 
 
Home Up Patient Emails Search Contents Contact Us
 

Mini-Gastric Bypass

   

Las Vegas, Nevada Dr. Rutledge
Email: DrR@clos.net or
Call Talk to Dr. Rutledge Now at: 702-215-9550
Free

Orlando, Florida  Dr. Peraglie

Email: DrP@clos.net or
Call Dr. Peraglie Now at: 407-922-3424
Free

   

MGB Cures Diabetes?

 

Start Here

Get Our
Patient Manual

Join Our
Mailing List

Patient
Application
Form

MGB
Animation

Watch 100s
of Videos

Got Lap-Band
Problems?

How Much
Does it Cost

Search

Mailing List

Pictures

MGB Papers

Daily Emails

PreOp
Process

MGB Manual

Meet Our
Patients

Patient
Application

Patient Letter

MGB Video

Our Brochure

Search

Follow Up

MGB vs RNY

Research

Take Survey

Discharge
Instructions

Home
Up

Revision: "Exit Strategy" 

Surgical treatment of obesity often fails. 

Consideration of any surgical treatment of obesity should also include an evaluation of the operation's "Exit Strategy," i.e. how the operation can be revised or reversed and what are the revision's associated risks and complications. 

Revision rates of up to 20-40% are reported with some forms of weight loss surgery because of excessive weight loss, severe unresponsive anemia, persistent nausea and vomiting, unsatisfactory weight loss resulting from staple line disruption, pouch dilatation, and/or stomal enlargement and other problems. 

Studies show that the morbidity and mortality are higher for revision than primary surgery . In a series reported by Sugerman and Wolper 46% of 122 gastroplasties for morbid obesity failed. They stated that "Conversion of a failed gastroplasty to a Roux-Y gastric bypass is a difficult procedure that carried a significantly higher complication rate." 

Lovig et. al. reported a five year follow-up of 174 morbidly obese patients with gastric banding performed between 1981 and 1985. In their series 48 patients (28%) had 60 late complications requiring 26 reoperations (14.9%). 

In a series of 170 patients undergoing Biliopancreatic Diversion followed for 7 years the re-operation rate because of these side-effects was 7%. 

Even newer types of surgery such as the silicone band types of surgery have revision rates of up to 10%. Miller and Hell performed 102 adjustable silicone gastric bandings and 54 Swedish adjustable gastric bandings. They report that the late complications that required reoperation were two pouch dilatations (1.3%), three band leakages (2%), one band migration (0.6%), and one late infection of the port (0.6%). Band removal was necessary in one patient because of an esophageal motility disorder. The overall reoperation rate was 7%. 

These revision rates are more than 10 times higher than the 0.6% rate in the  Mini-Gastric Bypass. 

In a series of 391 patients undergoing laparoscopic adjustable silicone gastric banding reported by Abu-Abeid and Szold a total of 26 (6.4%) reoperations were performed . In a series of 40 Lap-Band patients reported by Angrisani et. al. 8 of 40 patients who underwent laparoscopic adjustable silicone gastric banding experienced proximal gastric pouch dilation (18%) or band dislocation (3%). Debanding was performed in 3 patients with pouch dilation (8%), while in 4 the pouch dilation was successfully treated with deflation of the band. Two patients (5%) were treated with band repositioning. In a study by O'Brien et. al. prolapse of the stomach through the band occurred in 27 of 302 patients (9%). 

These reported rates of revision are much higher than the revision rate in this series of Mini-Gastric Bypass patients (revision rate of 0.6%). 

It appears that the Mini-Gastric Bypass has a revision rate that seems much lower than that reported for other forms of weight loss surgery. 

In addition, the reports of greatly increased risks after revision of other forms of weight loss surgery do not appear to be present in the Mini-Gastric Bypass. Revisions of the MGB were easily performed in an hour or less.

Unfortunately, the presently available surgical approaches have been fraught with such severe short and long-term complications that many physicians and surgeons prefer to avoid bariatric surgery entirely [i]. An ideal weight loss surgery should be effective, easy to perform and safe. It should have an simple and effective "Exit Strategy", that is, it should be easy to modify or reverse for inadequate weight loss, weight regain, excessive weight loss or other complications.

[i] Cowan GS Jr, Smalley MD, Defibaugh N, Cowan KB, Hiler ML, Sehnert W, James S., Obesity Stereotypes Among Physicians, Medical and College Students, Bariatric Surgery Patients and Families., Obes Surg. 1991 Jun;1(2):171-176

 

Home Up Patient Emails Search Contents Contact Us
This notice describes how information about you may be used and disclosed and how you can gain access to this information.  Please review carefully


Contact Information: -Telephones: *** CLOS West: 702-456-4643; Trish Lanman 702-376-3446, Sandy Brubaker 702-376-3647; Jennifer Brubaker 702-376-9339, Dr. Rutledge 702-215-9550; 989-450-8081 Kim Hazen 989-450-8081 *** CLOS Florida: Flo Ballengee 863-899-3463 Wayne Robbins 704-682-1549 Elizabeth Robbins 704-928-6693 Dr. Cesare Peraglie 407-922-3424


Email Us Anytime for Help:
Email: Dr. Rutledge DrR@clos.net, *** CLOS West: Trish Lanman Trish@clos.net, Sandy Brubaker SandyB@clos.net Dr. Rutledge DrR@clos.net, Kim Hazen khazen@clos.net *** CLOS Florida: Flo Ballengee flo@clos.net, Wayne Robbins wr@clos.net Elizabeth Robbins epr@clos.net Dr. Peraglie drp@clos.net


Addresses:
Address: *** CLOS West Office: Dr Robert Rutledge / CELOS, 98 E Lake Mead Parkway Suite 302, Henderson NV 89015, Office 702-456-4643, Office fax: 702-456-1173, Contacts: Trish Lanman 702-376-3446 Trish@clos.net, Sandy Brubaker 702-376-3647 SandyB@clos.net, Jennifer Brubaker 702-376-9339 Jen@clos.net, Dr. Rutledge 702-215-9550 Drr@clos.net Kim Hazen 989-450-8081 khazen@clos.net *** CLOS Florida: 40124 Highway 27, Suite 203, Davenport, FL 33837, Wayne Robbins 704-682-1549, wr@clos.net, Elizabeth Robbins 704-928-6693 epr@clos.net, Dr. Peraglie 407-922-3424 drp@clos.net


Warning: Gastric Bypass Surgery is a MAJOR surgical procedure. It can be associated with significant risks and complications, up to and including death. Weight loss surgery is a rapidly developing area of medicine. Bariatric surgery is filled with controversy. It is very important to take a careful and deliberate approach to considering surgery for the treatment of obesity.  

Disclaimer Notice:-Information on this web site is provided for informational purposes only.
-It is imperative that you consult your own physician regarding the applicability of any opinions or recommendations with respect to your symptoms or medical condition.
-Contact with this web site or Dr. Rutledge over the web site does not constitute a doctor patient relationship and for good quality medical care you must obtain advice and consultation form your own local physician.
-This site is intended as a resource for references on the treatment of obesity for health care professionals and educated consumers.
-The authors and editors have used sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publication.
-Medical knowledge changes rapidly. In view of the possibility of human error or changes in medical science, neither the authors nor the editors nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is in every respect accurate or complete, and they are not responsible for any errors or omissions or for the results obtained from the use of such information.
This information is not medical advice or diagnosis, nor is it to be construed as medical advice, medical information, medical diagnosis, or medical prescription for curing, removing, or preventing any disease, or related symptoms. You must seek the direct assistance, advice and evaluation of your own personal physician before acting on any information found herein. These statements have not been evaluated by the Food and Drug Administration.
-Readers are Strongly encouraged to discuss and confirm the information contained herein with your own physician.
Copyright © 1998 The Center for Laparoscopic Obesity Surgery